Prostate News Archive
22-Apr-2009
Agent Orange ups prostate cancer risk (UPI)
AUGUSTA , Ga., April 22 (UPI) -- U.S. veterans exposed to Agent Orange are at increased risk of aggressive recurrence of prostate cancer, researchers report. Researchers Discover Potential Functional Role of Genetic Variation in Prostate Cancer Risk (National Cancer Institute)
Researchers have described how a common genetic variation may be involved in the development of prostate cancer. The variant occurs in a gene known to be involved in prostate function. A 'Smart Bomb' for Prostate Cancer? (HealthDay via Yahoo! News)
TUESDAY, April 21 (HealthDay News) -- Researchers were able to shrink prostate cancer cells in mice using a new drug delivery method that combines imaging with chemotherapy in a single agent. Screening And Prostate-Cancer Mortality In A Randomized European Study (Medical News Today)
UroToday.com - The use of PSA screening for the detection and treatment of prostate cancer (CaP) has been controversial. Two articles on this topic appear in the March 18, 2009 online edition of the New England Journal of Medicine. This article by Professor Schöder and associates and the other by Dr. Andriole and colleagues are both reviewed in Urotoday. Potential genetic prostate cancer variation found (AFP via Yahoo! News)
Scientists have linked a common genetic variation to the development of prostate cancer, according to a study published Monday.
Back to Prostate News Archive
